Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial - Liang Dong; Zhi Cao; Meixia Chen; Yang Liu; Xinran Ma; Yuting Lu; Yan Zhang; Kaichao Feng; Yang Zhang; Zhenzhen Meng; Qingming Yang; Yao Wang; et al. (Nature Communications, 2024)